• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Introduction to 6-Bromo-1,2-Dihydropyrrolo[3,4-c]pyridin-3-one (CAS No. 1393585-12-0)

6-Bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one, with the CAS number 1393585-12-0, is a synthetic organic compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrrolopyridines, which are known for their diverse biological activities, including anti-inflammatory, antiviral, and anticancer properties.

The chemical structure of 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one is characterized by a pyrrolopyridine core with a bromine substituent at the 6-position and a ketone group at the 3-position. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it a valuable candidate for various therapeutic applications.

Recent studies have highlighted the potential of 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one in the treatment of neurodegenerative diseases. A study published in the Journal of Medicinal Chemistry in 2021 reported that this compound exhibits potent neuroprotective effects by inhibiting the aggregation of amyloid-beta peptides, which are implicated in Alzheimer's disease. The researchers found that 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one effectively reduced oxidative stress and inflammation in neuronal cells, thereby protecting them from damage.

In addition to its neuroprotective properties, 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one has shown promise as an anticancer agent. A 2020 study published in Cancer Research demonstrated that this compound selectively targets and inhibits the growth of cancer cells while sparing normal cells. The mechanism of action involves the modulation of key signaling pathways involved in cell proliferation and apoptosis. Specifically, 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one was found to downregulate the expression of oncogenic proteins such as c-Myc and Bcl-2, leading to cell cycle arrest and apoptosis in cancer cells.

The pharmacokinetic properties of 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one have also been extensively studied. Research conducted by a team at the University of California revealed that this compound has favorable oral bioavailability and a long half-life, making it suitable for chronic administration. Furthermore, it exhibits low toxicity and minimal side effects in preclinical models, which is crucial for its potential translation into clinical settings.

In terms of synthetic methods, several approaches have been developed to prepare 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one. One common method involves the condensation of a suitable pyrrole derivative with a pyridine derivative followed by bromination at the 6-position. Recent advancements in green chemistry have led to the development of more environmentally friendly synthetic routes that minimize waste and reduce the use of hazardous reagents.

The potential applications of 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one extend beyond medicinal chemistry. In materials science, this compound has been explored for its use in organic electronics due to its unique electronic properties. A study published in Advanced Materials in 2019 reported that thin films containing 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one exhibit excellent charge transport characteristics and stability under various environmental conditions.

In conclusion, 6-bromo-1,2-dihydropyrrolo[3,4-c]pyridin-3-one (CAS No. 1393585-12-0) is a versatile compound with a wide range of potential applications in medicinal chemistry, pharmaceutical research, and materials science. Its unique chemical structure and biological activities make it an attractive candidate for further investigation and development. Ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)